Trinity Biotech | TRIB - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Abbott USD 52.06B 69M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
EDAP TMS EUR 23.32M 4.5M 2025-09
J&J USD 81.19B 358M 2026-03
Mesa Laboratories USD 186.69M 8.22M 2025-12
OraSure Technologies USD 313.32M 27.5M 2026-03
Plus Therapeutics USD 11.96M 7.96M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Siemens EUR 64.39B 1.09B 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tosoh JPY 831.79B 28.49B 2026-03
Trinity Biotech USD -71.98M 17.26M 2025-12
Veracyte USD 1.34B 34.83M 2026-03